Clinical Trials · NCT02571140
A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Entera Bio Ltd.
- Enrollment
- 30
- Start date
- Oct 2013
- Locations
- See registry
- Primary endpoint
- Peak Plasma Concentration